Pulmonary Nodule, Multiple
16
1
1
6
Key Insights
Highlights
Success Rate
86% trial completion
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 49/100
6.3%
1 terminated out of 16 trials
85.7%
-0.8% vs benchmark
0%
0 trials in Phase 3/4
50%
3 of 6 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 6 completed trials
Clinical Trials (16)
Utility of CAML as Diagnostic for Early Stage Lung Cancer
DOLCE: Determining the Impact of Optellum's Lung Cancer Prediction Solution
Application of Carbon Dioxide for Identifying the Intersegmental Plane in Thoracoscopic Segmentectomy
Safety and Long-term Effects of COVID-19 Vaccines in Patients With Pulmonary Tumor
Dynamic Evolution of Pulmonary Nodules and Influence Factors of Its Clinical Decision-making
Nitrous Oxide for Identifying the Intersegmental Plane in Segmentectomy: A Randomized Controlled Trial
Virtual Management of Lung Nodules
Comparative Study on the Efficacy and Safety of Microwave Ablation and Lobectomy in the Treatment of Ground Glass Nodules Located in the Pulmonary Hilar Region
Clinical Evaluation of Primary Sampling Scatter Correction for Chest Tomosynthesis
IDEAL: Artificial Intelligence and Big Data for Early Lung Cancer Diagnosis Study
Breath Combined With CT for Diagnoses of Pulmonary Nodules
Ultra-Low Dose CT Denoising for Lung Nodule Detection
Lung Nodule Imaging Biobank for Radiomics and AI Research
Mixed Reality Technique Combined With 3D Printing Navigational Template for Localizing Pulmonary Nodules
Fluorescence-navigated Thoracoscopy for Detection of Small Pulmonary Nodules
Intravenous Indocyanine Green for Localization of Intra-thoracic Lesions